(firstQuint)ACURATE Neo AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis.

 Single arm, prospecitve, multicenter, non-randomized and open trial.

 The purpose of this trial is to collect and safety and performance data concerning the ACURATE neo cent AS Aortic Bioprosthesis and ACURATE neo cent AS TF Transfemoral Delivery System The ACURATE neo cent AS Aortic Bioprosthesis and ACURATE neo cent AS TF Transfemoral Delivery SystemACURATE neo cent are intended for use in minimally invasive, transcatheter aortic valve replacement (TAVR) using transfemoral access in patients presenting with severe aortic valve stenosis.

 The primary objective is to evaluate the safety and performance of the study device in patients presenting with severe aortic stenosis (AS) considered to be high risk for surgery.

 The secondary objective is to evaluate adverse events and study device performance.

.

 ACURATE Neo AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis@highlight

Cinical trial aimed at evaluating the safety and performance of the ACURATE neo cent AS Aortic Bioprosthesis and ACURATE neo cent AS TF Transfemoral Delivery System for CE mark approval purposes.

